BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghadiri M, Young PM, Traini D. Strategies to Enhance Drug Absorption via Nasal and Pulmonary Routes. Pharmaceutics 2019;11:E113. [PMID: 30861990 DOI: 10.3390/pharmaceutics11030113] [Cited by in Crossref: 93] [Cited by in F6Publishing: 96] [Article Influence: 23.3] [Reference Citation Analysis]
Number Citing Articles
1 Kumar A, Zhou L, Godse S, Sinha N, Ma D, Parmar K, Kumar S. Intranasal delivery of darunavir improves brain drug concentrations in mice for effective HIV treatment. Biochemistry and Biophysics Reports 2023;33:101408. [DOI: 10.1016/j.bbrep.2022.101408] [Reference Citation Analysis]
2 Trenkel M, Scherließ R. Optimising nasal powder drug delivery - Characterisation of the effect of excipients on drug absorption. Int J Pharm 2023;633:122630. [PMID: 36690127 DOI: 10.1016/j.ijpharm.2023.122630] [Reference Citation Analysis]
3 Yagi H, Tomono T, Handa Y, Saito N, Ukawa M, Miyata K, Shigeno K, Sakuma S. Performance of Cell-Penetrating Peptides Anchored to Polysaccharide Platforms Applied via Various Mucosal Routes as an Absorption Enhancer. Mol Pharm 2023;20:303-13. [PMID: 36484773 DOI: 10.1021/acs.molpharmaceut.2c00657] [Reference Citation Analysis]
4 Saalbach KP. Nasal and pulmonary routes of drug delivery. Novel Platforms for Drug Delivery Applications 2023. [DOI: 10.1016/b978-0-323-91376-8.00019-7] [Reference Citation Analysis]
5 Kommineni N, Sainaga Jyothi VGS, Butreddy A, Raju S, Shapira T, Khan W, Angsantikul P, Domb AJ. SNAC for Enhanced Oral Bioavailability: An Updated Review. Pharm Res 2022. [DOI: 10.1007/s11095-022-03459-9] [Reference Citation Analysis]
6 de Carvalho Patricio BF, da Silva Lopes Pereira JO, Sarcinelli MA, de Moraes BPT, Rocha HVA, Gonçalves-de-Albuquerque CF. Could the Lung Be a Gateway for Amphotericin B to Attack the Army of Fungi? Pharmaceutics 2022;14. [PMID: 36559201 DOI: 10.3390/pharmaceutics14122707] [Reference Citation Analysis]
7 Bseiso EA, AbdEl-Aal SA, Nasr M, Sammour OA, El Gawad NAA. Nose to brain delivery of melatonin lipidic nanocapsules as a promising post-ischemic neuroprotective therapeutic modality. Drug Deliv 2022;29:2469-80. [PMID: 35892291 DOI: 10.1080/10717544.2022.2104405] [Reference Citation Analysis]
8 Japiassu KB, Fay F, Marengo A, Louaguenouni Y, Cailleau C, Denis S, Chapron D, Tsapis N, Nascimento TL, Lima EM, Fattal E. Interplay between mucus mobility and alveolar macrophage targeting of surface-modified liposomes. J Control Release 2022;352:15-24. [PMID: 36209941 DOI: 10.1016/j.jconrel.2022.10.006] [Reference Citation Analysis]
9 Modaresi M, Heidarinejad G, Maddahian R, Firoozabadi B. Developing mucociliary clearance model for the numerical simulation of two-way coupling particulate flow inside the nasal cavity in the presence of deep breathing. Journal of Aerosol Science 2022. [DOI: 10.1016/j.jaerosci.2022.106120] [Reference Citation Analysis]
10 Qin L, Cui Z, Wu Y, Wang H, Zhang X, Guan J, Mao S. Challenges and Strategies to Enhance the Systemic Absorption of Inhaled Peptides and Proteins. Pharm Res 2022. [DOI: 10.1007/s11095-022-03435-3] [Reference Citation Analysis]
11 Bahadur S, Jha MK. Emerging nanoformulations for drug targeting to brain through intranasal delivery: A comprehensive review. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103932] [Reference Citation Analysis]
12 Inoue D, Yamashita A, To H. Development of In Vitro Evaluation System for Assessing Drug Dissolution Considering Physiological Environment in Nasal Cavity. Pharmaceutics 2022;14:2350. [DOI: 10.3390/pharmaceutics14112350] [Reference Citation Analysis]
13 Wu J, Zhu Z, Liu W, Zhang Y, Kang Y, Liu J, Hu C, Wang R, Zhang M, Chen L, Shao L. How Nanoparticles Open the Paracellular Route of Biological Barriers: Mechanisms, Applications, and Prospects. ACS Nano 2022;16:15627-52. [PMID: 36121682 DOI: 10.1021/acsnano.2c05317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhang YB, Xu D, Bai L, Zhou YM, Zhang H, Cui YL. A Review of Non-Invasive Drug Delivery through Respiratory Routes. Pharmaceutics 2022;14:1974. [PMID: 36145722 DOI: 10.3390/pharmaceutics14091974] [Reference Citation Analysis]
15 Tătaru I, Dragostin OM, Fulga I, Boros F, Carp A, Maftei A, Zamfir CL, Nechita A. The modern pharmacological approach to diabetes: innovative methods of monitoring and insulin treatment. Expert Rev Med Devices 2022. [PMID: 35962571 DOI: 10.1080/17434440.2022.2113387] [Reference Citation Analysis]
16 Prasher P, Sharma M, Singh SK, Gulati M, Jha NK, Gupta PK, Gupta G, Chellappan DK, Zacconi F, de Jesus Andreoli Pinto T, Chan Y, Liu G, Paudel K, Hansbro PM, George Oliver BG, Dua K. Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems. Chem Biol Interact 2022;:110048. [PMID: 35932910 DOI: 10.1016/j.cbi.2022.110048] [Reference Citation Analysis]
17 Kumar M, Dogra R, Mandal UK. Nanomaterial-based delivery of vaccine through nasal route: Opportunities, challenges, advantages, and limitations. Journal of Drug Delivery Science and Technology 2022;74:103533. [DOI: 10.1016/j.jddst.2022.103533] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Sastri KT, Gupta NV, M S, Chakraborty S, Kumar H, Chand P, Balamuralidhara V, Gowda D. Nanocarrier facilitated drug delivery to the brain through intranasal route: A promising approach to transcend bio-obstacles and alleviate neurodegenerative conditions. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103656] [Reference Citation Analysis]
19 Bseiso EA, Abd El-Aal SA, Nasr M, Sammour OA, Abd El Gawad NA. Intranasally administered melatonin core-shell polymeric nanocapsules: A promising treatment modality for cerebral ischemia. Life Sci 2022;:120797. [PMID: 35841976 DOI: 10.1016/j.lfs.2022.120797] [Reference Citation Analysis]
20 Kwon Y, Kang J, Kim Y, Kim D, Lee S, Park C. Preparation and Evaluation of Mucus-Penetrating Inhalable Microparticles of Tiotropium Bromide Containing Sodium Glycocholate. Pharmaceutics 2022;14:1409. [DOI: 10.3390/pharmaceutics14071409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Lofts A, Abu-Hijleh F, Rigg N, Mishra RK, Hoare T. Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs. CNS Drugs 2022. [PMID: 35759210 DOI: 10.1007/s40263-022-00930-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 McCollum CR, Courtney CM, O'Connor NJ, Aunins TR, Ding Y, Jordan TX, Rogers KL, Brindley S, Brown JM, Nagpal P, Chatterjee A. Nanoligomers Targeting Human miRNA for the Treatment of Severe COVID-19 Are Safe and Nontoxic in Mice. ACS Biomater Sci Eng 2022. [PMID: 35729709 DOI: 10.1021/acsbiomaterials.2c00510] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
23 Tai J, Han M, Lee D, Park I, Lee SH, Kim TH. Different Methods and Formulations of Drugs and Vaccines for Nasal Administration. Pharmaceutics 2022;14:1073. [DOI: 10.3390/pharmaceutics14051073] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Henriques P, Fortuna A, Doktorovová S. Spray dried powders for nasal delivery: Process and formulation considerations. Eur J Pharm Biopharm 2022:S0939-6411(22)00090-X. [PMID: 35568256 DOI: 10.1016/j.ejpb.2022.05.002] [Reference Citation Analysis]
25 Morales DE, Mousa SA. Intranasal Delivery in Glioblastoma treatment: Prospective Molecular Treatment Modalities. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e09517] [Reference Citation Analysis]
26 Sheikholeslami B, Lam NW, Dua K, Haghi M. Exploring the impact of physicochemical properties of liposomal formulations on their in vivo fate. Life Sciences 2022. [DOI: 10.1016/j.lfs.2022.120574] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
27 El Maalouf IR, Capoccia K, Priefer R. Non-invasive ways of administering insulin. Diabetes Metab Syndr 2022;16:102478. [PMID: 35397293 DOI: 10.1016/j.dsx.2022.102478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Yokel RA. Direct nose to the brain nanomedicine delivery presents a formidable challenge. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2022;14:e1767. [PMID: 34957707 DOI: 10.1002/wnan.1767] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Hinge NS, Kathuria H, Pandey MM. Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer's. Applied Materials Today 2022;26:101303. [DOI: 10.1016/j.apmt.2021.101303] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
30 Jain H, Prabhakar B, Shende P. Modulation of olfactory area for effective transportation of actives in CNS disorders. Journal of Drug Delivery Science and Technology 2022;68:103091. [DOI: 10.1016/j.jddst.2021.103091] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Sayyed ME, El-motaleb MA, Ibrahim IT, El-nabarawi MA, Ahmed MA. Intranasal administration of 99mTc-topiramate-loaded phospholipid magnesome potential route for enhanced brain delivery: Characterization, biodistribution, and pharmacokinetic behaviors. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103185] [Reference Citation Analysis]
32 Togami K, Ogasawara A, Irie S, Iwata K, Yamaguchi K, Tada H, Chono S. Improvement of the pharmacokinetics and antifibrotic effects of nintedanib by intrapulmonary administration of a nintedanib–hydroxypropyl-γ-cyclodextrin inclusion complex in mice with bleomycin-induced pulmonary fibrosis. European Journal of Pharmaceutics and Biopharmaceutics 2022. [DOI: 10.1016/j.ejpb.2022.02.009] [Reference Citation Analysis]
33 Chan Y, Ng SW, Soon L. Polymeric and Inorganic Nanoparticles Targeting Chronic Respiratory Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases 2022. [DOI: 10.1007/978-981-16-4392-7_18] [Reference Citation Analysis]
34 Sharma A, Mahanty J, Rasheed S, Kumar S, Singh H. Potential of essential oils as alternative permeation enhancers for transdermal delivery. World J Tradit Chin Med 2022;0:0. [DOI: 10.4103/2311-8571.351508] [Reference Citation Analysis]
35 Komalla V, Haghi M, Kayser V. Biologics and Vaccines for Nasal and Pulmonary Drug Delivery. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases 2022. [DOI: 10.1007/978-981-16-4392-7_21] [Reference Citation Analysis]
36 Stanković S, Tasić-kostov M. Formulation of biologics for alternative routes of administration: Current problems and perspectives. Acta fac medic Naissensis 2022;39:410-421. [DOI: 10.5937/afmnai39-35426] [Reference Citation Analysis]
37 Czechtizky W, Su W, Ripa L, Schiesser S, Höijer A, Cox RJ. Advances in the design of new types of inhaled medicines. Progress in Medicinal Chemistry 2022. [DOI: 10.1016/bs.pmch.2022.04.001] [Reference Citation Analysis]
38 Suresh V. Permeability Properties of an In Vitro Model of the Alveolar Epithelium. Cell Mol Bioeng 2021;14:653-9. [PMID: 34900017 DOI: 10.1007/s12195-021-00690-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Goel H, Kalra V, Verma SK, Dubey SK, Tiwary AK. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies. J Control Release 2021;341:782-811. [PMID: 34906605 DOI: 10.1016/j.jconrel.2021.12.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
40 Van Acker E, De Rijcke M, Liu Z, Asselman J, De Schamphelaere KAC, Vanhaecke L, Janssen CR. Sea Spray Aerosols Contain the Major Component of Human Lung Surfactant. Environ Sci Technol 2021;55:15989-6000. [PMID: 34793130 DOI: 10.1021/acs.est.1c04075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Yousfan A, Rubio N, Al-Ali M, Nattouf AH, Kafa H. Intranasal delivery of phenytoin-loaded nanoparticles to the brain suppresses pentylenetetrazol-induced generalized tonic clonic seizures in an epilepsy mouse model. Biomater Sci 2021;9:7547-64. [PMID: 34652351 DOI: 10.1039/d1bm01251g] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Casula E, Manconi M, Vázquez JA, Lopez-Mendez TB, Pedraz JL, Calvo E, Lozano A, Zaru M, Ascenso A, Manca ML. Design of a Nasal Spray Based on Cardiospermum halicacabum Extract Loaded in Phospholipid Vesicles Enriched with Gelatin or Chondroitin Sulfate. Molecules 2021;26:6670. [PMID: 34771079 DOI: 10.3390/molecules26216670] [Reference Citation Analysis]
43 Casula E, Letizia Manca M, Manconi M. An integrative review on the uses of plant-derived bioactives formulated in conventional and innovative dosage forms for the local treatment of damaged nasal cavity. Int J Pharm 2021;610:121229. [PMID: 34715259 DOI: 10.1016/j.ijpharm.2021.121229] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
44 Peswani Sajnani SL, Zhang Y, Vllasaliu D. Exosome-based therapies for mucosal delivery. Int J Pharm 2021;608:121087. [PMID: 34530100 DOI: 10.1016/j.ijpharm.2021.121087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Dholakia J, Prabhakar B, Shende P. Strategies for the delivery of antidiabetic drugs via intranasal route. Int J Pharm 2021;608:121068. [PMID: 34481011 DOI: 10.1016/j.ijpharm.2021.121068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
46 Casula E, Manconi M, Lopez-Mendez TB, Pedraz JL, Calvo E, Lozano A, Zaru M, Castangia I, Orrù G, Fais S, Manca ML. Complementary effect of Zingiber officinalis extract and citral in counteracting non allergic nasal congestion by simultaneous loading in ad hoc formulated phospholipid vesicles. Colloids Surf B Biointerfaces 2021;209:112170. [PMID: 34740093 DOI: 10.1016/j.colsurfb.2021.112170] [Reference Citation Analysis]
47 Cao H, Ma R, Chu S, Xi J, Yu L, Guo R. Synergistic effect of T80/B30 vesicles and T80/PN320 mixed micelles with Se/C on nasal mucosal immunity. Chinese Chemical Letters 2021;32:2761-4. [DOI: 10.1016/j.cclet.2021.03.029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
48 Rabiei M, Kashanian S, Samavati SS, Derakhshankhah H, Jamasb S, McInnes SJP. Characteristics of SARS-CoV2 that may be useful for nanoparticle pulmonary drug delivery. J Drug Target 2021;:1-11. [PMID: 34415800 DOI: 10.1080/1061186X.2021.1971236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Rabinowicz AL, Carrazana E, Maggio ET. Improvement of Intranasal Drug Delivery with Intravail® Alkylsaccharide Excipient as a Mucosal Absorption Enhancer Aiding in the Treatment of Conditions of the Central Nervous System. Drugs R D 2021;21:361-9. [PMID: 34435339 DOI: 10.1007/s40268-021-00360-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
50 Laffleur F, Bauer B. Progress in nasal drug delivery systems. Int J Pharm 2021;607:120994. [PMID: 34390810 DOI: 10.1016/j.ijpharm.2021.120994] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
51 Upadhaya PG, Pulakkat S, Patravale VB. Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management. Drug Deliv Transl Res 2020;10:1044-56. [PMID: 32221847 DOI: 10.1007/s13346-020-00747-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
52 Sodha SJ, Patel M, Nagarkar R, Mohammed IA, Patel H. Translation of pulmonary protein therapy from bench to bedside: Addressing the bioavailability challenges. Journal of Drug Delivery Science and Technology 2021;64:102664. [DOI: 10.1016/j.jddst.2021.102664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Deruyver L, Rigaut C, Lambert P, Haut B, Goole J. The importance of pre-formulation studies and of 3D-printed nasal casts in the success of a pharmaceutical product intended for nose-to-brain delivery. Adv Drug Deliv Rev 2021;175:113826. [PMID: 34119575 DOI: 10.1016/j.addr.2021.113826] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
54 de Cristo Soares Alves A, Lavayen V, de Fraga Dias A, Bruinsmann FA, Scholl JN, Cé R, Visioli F, Oliveira Battastini AM, Stanisçuaski Guterres S, Figueiró F, Raffin Pohlmann A. EGFRvIII peptide nanocapsules and bevacizumab nanocapsules: a nose-to-brain multitarget approach against glioblastoma. Nanomedicine (Lond) 2021;16:1775-90. [PMID: 34313137 DOI: 10.2217/nnm-2021-0169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Costa CP, Cunha S, Moreira JN, Silva R, Gil-Martins E, Silva V, Azevedo L, Peixoto AF, Sousa Lobo JM, Silva AC. Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells. Int J Pharm 2021;607:120933. [PMID: 34324988 DOI: 10.1016/j.ijpharm.2021.120933] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
56 Wang L, Yin Q, Liu C, Tang Y, Sun C, Zhuang J. Nanoformulations of Ursolic Acid: A Modern Natural Anticancer Molecule. Front Pharmacol 2021;12:706121. [PMID: 34295253 DOI: 10.3389/fphar.2021.706121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
57 Basinska T, Gadzinowski M, Mickiewicz D, Slomkowski S. Functionalized Particles Designed for Targeted Delivery. Polymers (Basel) 2021;13:2022. [PMID: 34205672 DOI: 10.3390/polym13122022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
58 Miyake M, Minami T, Maruyama M, Mukai T, Higaki K. Spermine with Sodium Taurocholate Enhances Pulmonary Absorption of Macromolecules in Rats. J Pharm Sci 2021:S0022-3549(21)00305-1. [PMID: 34118254 DOI: 10.1016/j.xphs.2021.06.015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Wu Y, Zhang H, Zhang R, Cao G, Li Q, Zhang B, Wang Y, Yang C. Serum metabolome and gut microbiome alterations in broiler chickens supplemented with lauric acid. Poult Sci 2021;100:101315. [PMID: 34280650 DOI: 10.1016/j.psj.2021.101315] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Truzzi E, Rustichelli C, de Oliveira Junior ER, Ferraro L, Maretti E, Graziani D, Botti G, Beggiato S, Iannuccelli V, Lima EM, Dalpiaz A, Leo E. Nasal biocompatible powder of Geraniol oil complexed with cyclodextrins for neurodegenerative diseases: physicochemical characterization and in vivo evidences of nose to brain delivery. J Control Release 2021;335:191-202. [PMID: 34019946 DOI: 10.1016/j.jconrel.2021.05.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
61 Debnath SK, Srivastava R, Debnath M, Omri A. Status of inhalable antimicrobial agents for lung infection: progress and prospects. Expert Rev Respir Med 2021;:1-20. [PMID: 33866900 DOI: 10.1080/17476348.2021.1919514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 Fröhlich E, Salar-Behzadi S. Oral inhalation for delivery of proteins and peptides to the lungs. Eur J Pharm Biopharm 2021;163:198-211. [PMID: 33852968 DOI: 10.1016/j.ejpb.2021.04.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
63 Dretchen KL, Mesa Z, Robben M, Slade D, Hill S, Croutch C, Kappeler K, Mesa M. Intranasal epinephrine in dogs: Pharmacokinetic and heart rate effects. Pharmacol Res Perspect 2020;8:e00587. [PMID: 32302068 DOI: 10.1002/prp2.587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
64 Ragupathy S, Brunner J, Borchard G. Short peptide sequence enhances epithelial permeability through interaction with protein kinase C. Eur J Pharm Sci 2021;160:105747. [PMID: 33582284 DOI: 10.1016/j.ejps.2021.105747] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
65 Gao Y, Sun Y, Liao G, Zhang H, Long Q. DSPE-PEG polymers for improving pulmonary absorption of poorly absorbed macromolecules in rats and relative mechanism. Drug Dev Ind Pharm 2021;47:337-46. [PMID: 33502913 DOI: 10.1080/03639045.2021.1879837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Khatoon R, Alam MA, Sharma PK. Current approaches and prospective drug targeting to brain. Journal of Drug Delivery Science and Technology 2021;61:102098. [DOI: 10.1016/j.jddst.2020.102098] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Keller LA, Merkel O, Popp A. Intranasal drug delivery: opportunities and toxicologic challenges during drug development. Drug Deliv Transl Res 2021. [PMID: 33491126 DOI: 10.1007/s13346-020-00891-5] [Cited by in Crossref: 57] [Cited by in F6Publishing: 74] [Article Influence: 28.5] [Reference Citation Analysis]
68 Dubey SK, Parab S, Dabholkar N, Agrawal M, Singhvi G, Alexander A, Bapat RA, Kesharwani P. Oral peptide delivery: challenges and the way ahead. Drug Discov Today 2021;26:931-50. [PMID: 33444788 DOI: 10.1016/j.drudis.2021.01.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
69 Vora D, Kincaid AE, Tolman J, Chauhan H. Characterization and Systemic Delivery of Dibenzoylmethane via the Intranasal Route. AAPS PharmSciTech 2021;22:30. [PMID: 33404926 DOI: 10.1208/s12249-020-01904-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Madav Y, Wairkar S. Strategies for enhanced direct nose-to-brain drug delivery. Direct Nose-to-Brain Drug Delivery 2021. [DOI: 10.1016/b978-0-12-822522-6.00014-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Dhanjal DS, Mehta M, Chopra C, Singh R, Sharma P, Chellappan DK, Tambuwala MM, Bakshi HA, Aljabali AA, Gupta G, Nammi S, Prasher P, Dua K, Satija S. Novel Controlled Release Pulmonary Drug Delivery Systems: Current updates and Challenges. Modeling and Control of Drug Delivery Systems 2021. [DOI: 10.1016/b978-0-12-821185-4.00001-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Tan ZM, Lai GP, Pandey M, Srichana T, Pichika MR, Gorain B, Bhattamishra SK, Choudhury H. Novel Approaches for the Treatment of Pulmonary Tuberculosis. Pharmaceutics 2020;12:E1196. [PMID: 33321797 DOI: 10.3390/pharmaceutics12121196] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
73 Rabiee N, Ahmadi S, Afshari R, Khalaji S, Rabiee M, Bagherzadeh M, Fatahi Y, Dinarvand R, Tahriri M, Tayebi L, Hamblin MR, Webster TJ. Polymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer's Disease. Adv Therap 2021;4:2000076. [DOI: 10.1002/adtp.202000076] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
74 Alhudaithi SS, Almuqbil RM, Zhang H, Bielski ER, Du W, Sunbul FS, Bos PD, da Rocha SRP. Local Targeting of Lung-Tumor-Associated Macrophages with Pulmonary Delivery of a CSF-1R Inhibitor for the Treatment of Breast Cancer Lung Metastases. Mol Pharm 2020;17:4691-703. [PMID: 33170724 DOI: 10.1021/acs.molpharmaceut.0c00983] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
75 Jin X, Song L, Ma CC, Zhang YC, Yu S. Pulmonary route of administration is instrumental in developing therapeutic interventions against respiratory diseases. Saudi Pharm J 2020;28:1655-65. [PMID: 33424258 DOI: 10.1016/j.jsps.2020.10.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
76 Lam JKW, Cheung CCK, Chow MYT, Harrop E, Lapwood S, Barclay SIG, Wong ICK. Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic. Adv Drug Deliv Rev 2020;160:234-43. [PMID: 33137363 DOI: 10.1016/j.addr.2020.10.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
77 Cidem A, Bradbury P, Traini D, Ong HX. Modifying and Integrating in vitro and ex vivo Respiratory Models for Inhalation Drug Screening. Front Bioeng Biotechnol 2020;8:581995. [PMID: 33195144 DOI: 10.3389/fbioe.2020.581995] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
78 Formiga FR, Leblanc R, de Souza Rebouças J, Farias LP, de Oliveira RN, Pena L. Ivermectin: an award-winning drug with expected antiviral activity against COVID-19. J Control Release 2021;329:758-61. [PMID: 33038449 DOI: 10.1016/j.jconrel.2020.10.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
79 Kashapov R, Gaynanova G, Gabdrakhmanov D, Kuznetsov D, Pavlov R, Petrov K, Zakharova L, Sinyashin O. Self-Assembly of Amphiphilic Compounds as a Versatile Tool for Construction of Nanoscale Drug Carriers. Int J Mol Sci 2020;21:E6961. [PMID: 32971917 DOI: 10.3390/ijms21186961] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 11.0] [Reference Citation Analysis]
80 Zhang Y, Zhang H, Ghosh D, Williams RO 3rd. Just how prevalent are peptide therapeutic products? A critical review. Int J Pharm 2020;587:119491. [PMID: 32622810 DOI: 10.1016/j.ijpharm.2020.119491] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
81 Day CPF, Miloserdov A, Wildish-Jones K, Pearson E, Carruthers AE. Quantifying the hygroscopic properties of cyclodextrin containing aerosol for drug delivery to the lungs. Phys Chem Chem Phys 2020;22:11327-36. [PMID: 32406900 DOI: 10.1039/d0cp01385d] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
82 Badhe RV, Nipate SS. Nasal Bioadhesive Drug Delivery Systems and Their Applications. In: Mittal K, Bakshi IS, Narang JK, editors. Bioadhesives in Drug Delivery. Wiley; 2020. pp. 259-305. [DOI: 10.1002/9781119640240.ch10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
83 Bahmanpour A, Ghaffari M, Milan PB, Moztarzadeh F, Mozafari M. Synthesis and characterization of thermosensitive hydrogel based on quaternized chitosan for intranasal delivery of insulin. Biotechnol Appl Biochem 2021;68:247-56. [PMID: 32250466 DOI: 10.1002/bab.1917] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
84 Skoulas D, Stuettgen V, Gaul R, Cryan SA, Brayden DJ, Heise A. Amphiphilic Star Polypept(o)ides as Nanomeric Vectors in Mucosal Drug Delivery. Biomacromolecules 2020;21:2455-62. [PMID: 32343127 DOI: 10.1021/acs.biomac.0c00381] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
85 Sun Y, Li L, Xie H, Wang Y, Gao S, Zhang L, Bo F, Yang S, Feng A. Primary Studies on Construction and Evaluation of Ion-Sensitive in situ Gel Loaded with Paeonol-Solid Lipid Nanoparticles for Intranasal Drug Delivery. Int J Nanomedicine 2020;15:3137-60. [PMID: 32440115 DOI: 10.2147/IJN.S247935] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
86 Far J, Abdel-Haq M, Gruber M, Abu Ammar A. Developing Biodegradable Nanoparticles Loaded with Mometasone Furoate for Potential Nasal Drug Delivery. ACS Omega 2020;5:7432-9. [PMID: 32280885 DOI: 10.1021/acsomega.0c00111] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
87 Kim SH, Thambi T, Giang Phan V, Lee DS. Modularly engineered alginate bioconjugate hydrogel as biocompatible injectable scaffold for in situ biomineralization. Carbohydrate Polymers 2020;233:115832. [DOI: 10.1016/j.carbpol.2020.115832] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 9.7] [Reference Citation Analysis]
88 Truzzi E, Nascimento TL, Iannuccelli V, Costantino L, Lima EM, Leo E, Siligardi C, Gualtieri ML, Maretti E. In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment? Nanomaterials (Basel) 2020;10:E568. [PMID: 32245153 DOI: 10.3390/nano10030568] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
89 Gomes Dos Reis L, Traini D. Advances in the use of cell penetrating peptides for respiratory drug delivery. Expert Opin Drug Deliv 2020;17:647-64. [PMID: 32138567 DOI: 10.1080/17425247.2020.1739646] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
90 Zhang X, Yue X, Cui Y, Zhao Z, Huang Y, Cai S, Wang G, Wang W, Hugh S, Pan X, Wu C, Tan W. A Systematic Safety Evaluation of Nanoporous Mannitol Material as a Dry-Powder Inhalation Carrier System. J Pharm Sci 2020;109:1692-702. [PMID: 31987851 DOI: 10.1016/j.xphs.2020.01.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
91 Mishra B, Singh J. Novel drug delivery systems and significance in respiratory diseases. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems 2020. [DOI: 10.1016/b978-0-12-820658-4.00004-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
92 Maurya P, Singh S, Saraf SA. Inhalable hybrid nanocarriers for respiratory disorders. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems 2020. [DOI: 10.1016/b978-0-12-820658-4.00013-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
93 Sosnowski TR. Inhalation as a Means of Systemic Drug Delivery. Healthy Ageing and Longevity 2020. [DOI: 10.1007/978-3-030-54490-4_12] [Reference Citation Analysis]
94 Shukla SD, Swaroop Vanka K, Chavelier A, Shastri MD, Tambuwala MM, Bakshi HA, Pabreja K, Mahmood MQ, O’toole RF. Chronic respiratory diseases: An introduction and need for novel drug delivery approaches. Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems 2020. [DOI: 10.1016/b978-0-12-820658-4.00001-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
95 Dogbe MG, Mafilaza AY, Eleutério CV, Cabral-Marques H, Simões S, Gaspar MM. Pharmaceutical Benefits of Fluticasone Propionate Association to Delivery Systems: In Vitro and In Vivo Evaluation. Pharmaceutics 2019;11:E521. [PMID: 31658657 DOI: 10.3390/pharmaceutics11100521] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
96 Maretti E, Rustichelli C, Lassinantti Gualtieri M, Costantino L, Siligardi C, Miselli P, Buttini F, Montecchi M, Leo E, Truzzi E, Iannuccelli V. The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant. Pharmaceutics 2019;11:E508. [PMID: 31581554 DOI: 10.3390/pharmaceutics11100508] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
97 Maher S, Casettari L, Illum L. Transmucosal Absorption Enhancers in the Drug Delivery Field. Pharmaceutics 2019;11:E339. [PMID: 31311173 DOI: 10.3390/pharmaceutics11070339] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]